StonvexLoading…
StonvexStonvexStonvexCore line items from DMRC's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $7.58M | $33.91M | $25.00M | $17.38M |
Operating Income | $-7.14M | $-33.16M | $-28.87M | $-20.50M |
Net Income | $-6.97M | $-32.31M | $-28.10M | $-19.95M |
EPS (Diluted) | $-0.32 | $-1.49 | $-1.30 | $-0.93 |
Total Assets | $48.51M | $52.96M | $55.44M | $60.75M |
Total Liabilities | $14.44M | $12.73M | $14.05M | $14.26M |
Cash & Equivalents | $8.82M | $9.82M | $9.10M | $10.11M |
Free Cash Flow OCF − CapEx | $-1.89M | $-12.35M | $-13.24M | $-10.43M |
Shares Outstanding | 22.14M | 21.90M | 21.75M | 21.66M |